These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 37465857)
41. T-cell replete haploidentical stem cell transplantation attenuates the prognostic impact of FLT3-ITD in acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Canaani J; Labopin M; Huang XJ; Arcese W; Ciceri F; Blaise D; Irrera G; Corral LL; Bruno B; Santarone S; Van Lint MT; Vitek A; Esteve J; Mohty M; Nagler A Am J Hematol; 2018 Jun; 93(6):736-744. PubMed ID: 29498106 [TBL] [Abstract][Full Text] [Related]
42. Impact of FLT3 internal tandem duplication and NPM1 mutations in acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation. Khanolkar RA; Faridi RM; Kinzel M; Jamani K; Savoie ML; Shafey M; Khan FM; Storek J Cytotherapy; 2022 Apr; 24(4):413-420. PubMed ID: 34863627 [TBL] [Abstract][Full Text] [Related]
43. NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia. Shiba N; Ichikawa H; Taki T; Park MJ; Jo A; Mitani S; Kobayashi T; Shimada A; Sotomatsu M; Arakawa H; Adachi S; Tawa A; Horibe K; Tsuchida M; Hanada R; Tsukimoto I; Hayashi Y Genes Chromosomes Cancer; 2013 Jul; 52(7):683-93. PubMed ID: 23630019 [TBL] [Abstract][Full Text] [Related]
44. Prognostic impact of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia patients with internal tandem duplication of FLT3. Lin PH; Lin CC; Yang HI; Li LY; Bai LY; Chiu CF; Liao YM; Lin CY; Hsieh CY; Lin CY; Ho CM; Yang SF; Peng CT; Tsai FJ; Yeh SP Leuk Res; 2013 Mar; 37(3):287-92. PubMed ID: 23276395 [TBL] [Abstract][Full Text] [Related]
45. Outcome of Childhood Acute Myeloid Leukemia With FLT3-ITD Mutation: The Experience of Children's Cancer Hospital Egypt, 2007-17. Semary SF; Hammad M; Soliman S; Yassen D; Gamal M; Albeltagy D; Hamdy N; Mahmoud S Clin Lymphoma Myeloma Leuk; 2020 Aug; 20(8):e529-e541. PubMed ID: 32473792 [TBL] [Abstract][Full Text] [Related]
46. DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation. Ahn JS; Kim HJ; Kim YK; Lee SS; Jung SH; Yang DH; Lee JJ; Kim NY; Choi SH; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Kim DD Biol Blood Marrow Transplant; 2016 Jan; 22(1):61-70. PubMed ID: 26234722 [TBL] [Abstract][Full Text] [Related]
47. Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia. Shamaa S; Laimon N; Aladle DA; Azmy E; Elghannam DM; Salem DA; Taalab MM Hematology; 2014 Jan; 19(1):22-30. PubMed ID: 23540998 [TBL] [Abstract][Full Text] [Related]
48. Clinical Effect of Combined Mutations in DNMT3A, FLT3-ITD, and NPM1 Among Egyptian Acute Myeloid Leukemia Patients. El Gammal MM; Ebid GT; Madney YM; Abo-Elazm OM; Kelany AK; Torra OS; Radich JP Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e281-e290. PubMed ID: 30926392 [TBL] [Abstract][Full Text] [Related]
50. Adverse impact of a high allelic burden FLT3-ITD mutation on allogeneic hematopoietic stem cell transplantation in patients with cytogenetically normal AML. Wan L; Ding S; Xu M; Lv K; Du Y; Wu D; Xu M; Liu Y Int J Hematol; 2022 Nov; 116(5):731-743. PubMed ID: 35857193 [TBL] [Abstract][Full Text] [Related]
51. Prognostication refinement in NPM1-mutated acute myeloid leukemia stratified by FLT3-ITD status with different induction doses of cytarabine. Wang B; Hua X; Zhang J; Gu W; Li H Cancer Med; 2023 Apr; 12(8):9420-9433. PubMed ID: 36808479 [TBL] [Abstract][Full Text] [Related]
52. Patient-specific analysis of FLT3 internal tandem duplications for the prognostication and monitoring of acute myeloid leukemia. Schiller J; Praulich I; Krings Rocha C; Kreuzer KA Eur J Haematol; 2012 Jul; 89(1):53-62. PubMed ID: 22458420 [TBL] [Abstract][Full Text] [Related]
53. FLT3 and NPM1 mutations in Chinese patients with acute myeloid leukemia and normal cytogenetics. Wang L; Xu WL; Meng HT; Qian WB; Mai WY; Tong HY; Mao LP; Tong Y; Qian JJ; Lou YJ; Chen ZM; Wang YG; Jin J J Zhejiang Univ Sci B; 2010 Oct; 11(10):762-70. PubMed ID: 20872983 [TBL] [Abstract][Full Text] [Related]
54. Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML. Ahn JS; Kim HJ; Kim YK; Jung SH; Yang DH; Lee JJ; Kim NY; Choi SH; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Kim DD Ann Hematol; 2016 Mar; 95(4):625-35. PubMed ID: 26692090 [TBL] [Abstract][Full Text] [Related]
55. Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia. Mohanty S; Jyotsana N; Sharma A; Kloos A; Gabdoulline R; Othman B; Lai CK; Schottmann R; Mandhania M; Schmoellerl J; Grebien F; Ramsay E; Thomas A; Vornlocher HP; Ganser A; Thol F; Heuser M Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32993115 [TBL] [Abstract][Full Text] [Related]
56. Durable remission of post-transplant relapsed FLT3-ITD AML in response to gilteritinib administration after a second transplant from the same donor. Ando T; Sano H; Yokoo M; Kusaba K; Kidoguchi K; Yamaguchi K; Katsuya H; Yoshihara S; Kubota Y; Kojima K; Kimura S Int J Hematol; 2020 Aug; 112(2):249-253. PubMed ID: 32185622 [TBL] [Abstract][Full Text] [Related]
57. Prognostic Relevance of DNMT3A, FLT3 and NPM1 Mutations in Syrian Acute Myeloid Leukemia Patients. Moualla Y; Moassass F; Al-Halbi B; Al-Achkar W; Georgeos M; Yazigi H; Khamis A Asian Pac J Cancer Prev; 2022 Apr; 23(4):1387-1395. PubMed ID: 35485701 [TBL] [Abstract][Full Text] [Related]